Substance
GOLIMUMAB
Global reference: every product and company linked to this substance.
- cas: 476181-74-5
- ncit: C87766
- rxnorm: 819300
- unii: 91X1KLU43E
CNTO 148 · CNTO-148 · golimumab [INN] · GOLIMUMAB [JAN] · GOLIMUMAB [USAN] · Golimumab [WHO-DD] · SIMPONI
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | SIMPONI ARIA | Q2 2026 | $618.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- SIMPONI · JOHNSON & JOHNSON COMMON STOCK
- SIMPONI ARIA · JOHNSON & JOHNSON COMMON STOCK
- SIMPONI · JOHNSON & JOHNSON COMMON STOCK